Chemical destruction and disposal of antineoplastic drugs
Gallelli, J.F.; Mahar, H.
American Journal of Hospital Pharmacy 43(7): 1679
1986
ISSN/ISBN: 0002-9289 PMID: 3752099 Document Number: 280885
Document emailed within 1 workday
Related Documents
Wrześniok, D.; Buszman, E.; Matusiński, B. 2003: Drugs ototoxicity. Part II. Loop diuretics, nonsteroidal anti-inflammatory drugs, antineoplastic and antimalarial drugs Wiadomosci Lekarskie 56(7-8): 369-374Zweidinger, R.A.; Sheldon, L.S. 1988: Chemical waste disposal sites: sampling and analysis Iarc Scientific Publications 85: 179-185
Trissel, L.A.; Parks, N.P.; Santiago, N.M. 1991: Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection American Journal of Hospital Pharmacy 48(10): 2186-2189
Vogel, G. 2001: Pharmacology. How the body's 'garbage disposal' may inactivate drugs Science 291(5501): 35-37
Stoĭko, T.G.; Mazeĭ, I.A.; Tsyganov, A.N.; Tikhonenkov, D.V. 2006: Impact of chemical weapon destruction on the structure of lake zoohydrobiont community Izvestiia Akademii Nauk. Seriia Biologicheskaia 13(2): 225-231
Williams, S.F.; Schilsky, R.L. 2000: Antineoplastic drugs administered during pregnancy Seminars in Oncology 27(6): 618-622
Williams, S.F.; Schilsky, R.L. 2000: Antineoplastic drugs administered during pregnancy Seminars in Oncology 27(6): 618-622
Ng, L.M.; Jaffe, N. 1970: Possible hazards of handling antineoplastic drugs Pediatrics 46(4): 648-649
Neiger, R. 1996: Guidelines for the handling of antineoplastic drugs Schweizer Archiv für Tierheilkunde 138(8): 383-386
Greco, F.A.; Hande, K.R. 1979: The clinical pharmacology and use of antineoplastic drugs Journal of the Tennessee Medical Association 72(1): 23-33
Nissen, N.I. 1972: Evaluation of the clinical effect of antineoplastic drugs Ugeskrift for Laeger 134(25): 1345-1346
Szmigiero, L. 1988: Topoisomerase Ii as a cellular receptor of various antineoplastic drugs Postepy Biochemii 34(3): 147-152
Buja, L.M.; Ferrans, V.J. 1975: Myocardial injury produced by antineoplastic drugs Recent Advances in Studies on Cardiac Structure and Metabolism 6: 487-497
Kuduk-Jaworska, J. 1984: Platinum complexes as potential antineoplastic drugs Postepy Higieny i Medycyny Doswiadczalnej 38(3): 281-322
Lipatova, T.E.; Alekseeva, T.T.; Bakalo, L.A.; Tereshchenko, T.L. 1980: Chemical composition of linear polyurethanes and the rate of their destruction in physiological solution and animal body Polimery W Medycynie 10(1): 19-29
Pavone-Macaluso, M.; Rizzo, F.P.; Caramia, G.; Ascoli, R.; Gebbia, N.; Biondo, F.; Mazzarese, S.; Butera, G. 1975: Absorption of drugs through the bladder. Experiences with antineoplastic agents Recenti Progressi in Medicina 59(5): 479-496
Luisetti, M.; Peona, V.; Salmona, M.; Pagnoni, A.M.; Villani, F.; Knerich, R.; Genghini, M.; Abbà, L.; Pozzi, E. 1986: Ambroxol and pulmonary toxicity induced by antineoplastic drugs International Journal of Clinical Pharmacology Research 6(2): 129-136
Gallelli, J.F. 1982: Evaluating the potential hazard of handling antineoplastic drugs American Journal of Hospital Pharmacy 39(11): 1877
Zhao, Z.Z.; Huang, M.T. 1992: A study of vitamin inhibition on the mutagenicity of the antineoplastic drugs Zhonghua Yu Fang Yi Xue Za Zhi 26(5): 291-293
Valanis, B.; Shortridge, L. 1987: Self protective practices of nurses handling antineoplastic drugs Oncology Nursing Forum 14(3): 23-27